#155099

Anti-vWFACTOR AGII pp [MBC 239.3]

Cat. #155099

Anti-vWFACTOR AGII pp [MBC 239.3]

Cat. #: 155099

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: von Willebrand Factor Antigen II (vWf:AgII)

Class: Monoclonal

Application: ELISA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Versiti Blood Research Institute

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-vWFACTOR AGII pp [MBC 239.3]
  • Alternate name: vWFpp
  • Research fields: Immunology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Purpose: Marker
  • Conjugation: Unconjugated
  • Molecular weight: 75 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA
  • Description: Von Willebrand factor (vWF) is a multimeric plasma glycoprotein that functions in hemostasis as the initiator of platelet adhesion at the site of vascular injury and as the carrier of the anti-hemophilic factor, factor VIII (FVIII). Hereditary or acquired defects of VWF lead to von Willebrand disease (vWD), a bleeding diathesis of the skin and mucous membranes, causing nosebleeds, menorrhagia, and gastrointestinal bleeding.
  • Immunogen: vWF Pro-peptide formerly named Human-AGII
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: IgG1

Target Details

  • Target: von Willebrand Factor Antigen II (vWf:AgII)
  • Molecular weight: 75 kDa
  • Tissue cell line specificity: Mouse
  • Target background: Von Willebrand factor (vWF) is a multimeric plasma glycoprotein that functions in hemostasis as the initiator of platelet adhesion at the site of vascular injury and as the carrier of the anti-hemophilic factor, factor VIII (FVIII). Hereditary or acquired defects of VWF lead to von Willebrand disease (vWD), a bleeding diathesis of the skin and mucous membranes, causing nosebleeds, menorrhagia, and gastrointestinal bleeding.

Applications

  • Application: ELISA

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Haberichter et al. 2006. Blood. 108(10):3344-51. PMID: 16835381.